Terms: = Colorectal cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Treatment
1008 results:
1. Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement.
Wlodarski MW; Vlachos A; Farrar JE; Da Costa LM; Kattamis A; Dianzani I; Belendez C; Unal S; Tamary H; Pasauliene R; Pospisilova D; de la Fuente J; Iskander D; Wolfe L; Liu JM; Shimamura A; Albrecht K; Lausen B; Bechensteen AG; Tedgard U; Puzik A; Quarello P; Ramenghi U; Bartels M; Hengartner H; Farah RA; Al Saleh M; Hamidieh AA; Yang W; Ito E; Kook H; Ovsyannikova G; Kager L; Gleizes PE; Dalle JH; Strahm B; Niemeyer CM; Lipton JM; Leblanc TM;
Lancet Haematol; 2024 May; 11(5):e368-e382. PubMed ID: 38697731
[TBL] [Abstract] [Full Text] [Related]
2. The role of piRNAs in predicting and prognosing in cancer: a focus on piRNA-823 (a systematic review and meta-analysis).
Taghizadeh M; Jafari-Koshki T; Jafarlou V; Raeisi M; Alizadeh L; Roosta Y; Matin S; Jabari R; Sur D; Karimi A
BMC Cancer; 2024 Apr; 24(1):484. PubMed ID: 38627675
[TBL] [Abstract] [Full Text] [Related]
3. Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
Kim S; Ghiringhelli F; de la Fouchardière C; Evesque L; Smith D; Badet N; Samalin E; Lopez-Trabada Ataz D; Parzy A; Desramé J; Baba Hamed N; Buecher B; Tougeron D; Bouché O; Dahan L; Chibaudel B; El Hajbi F; Mineur L; Dubreuil O; Ben Abdelghani M; Pecout S; Bibeau F; Herfs M; Garcia ML; Meurisse A; Vernerey D; Taïeb J; Borg C
Lancet Oncol; 2024 Apr; 25(4):518-528. PubMed ID: 38547895
[TBL] [Abstract] [Full Text] [Related]
4. Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGE.
Cartwright E; Slater S; Saffery C; Tran A; Turkes F; Smith G; Aresu M; Kohoutova D; Terlizzo M; Zhitkov O; Rana I; Johnston EW; Sanna I; Smyth E; Mansoor W; Fribbens C; Rao S; Chau I; Starling N; Cunningham D
ESMO Open; 2024 Apr; 9(4):102971. PubMed ID: 38518549
[TBL] [Abstract] [Full Text] [Related]
5. Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial.
Wang F; Jin Y; Wang M; Luo HY; Fang WJ; Wang YN; Chen YX; Huang RJ; Guan WL; Li JB; Li YH; Wang FH; Hu XH; Zhang YQ; Qiu MZ; Liu LL; Wang ZX; Ren C; Wang DS; Zhang DS; Wang ZQ; Liao WT; Tian L; Zhao Q; Xu RH
Nat Med; 2024 Apr; 30(4):1035-1043. PubMed ID: 38438735
[TBL] [Abstract] [Full Text] [Related]
6. Clinical efficacy of acupuncture in treating postoperative gastrointestinal dysfunction of colorectal cancer, a systematic review and meta analysis.
Zhou T; Wang S; Fan BJ; Zhang LX; Hu SH; Hou W
Zhen Ci Yan Jiu; 2024 Feb; 49(2):208-219. PubMed ID: 38413043
[TBL] [Abstract] [Full Text] [Related]
7. Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.
Shitara K; Muro K; Watanabe J; Yamazaki K; Ohori H; Shiozawa M; Takashima A; Yokota M; Makiyama A; Akazawa N; Ojima H; Yuasa Y; Miwa K; Yasui H; Oki E; Sato T; Naitoh T; Komatsu Y; Kato T; Mori I; Yamanaka K; Hihara M; Soeda J; Misumi T; Yamamoto K; Yamashita R; Akagi K; Ochiai A; Uetake H; Tsuchihara K; Yoshino T
Nat Med; 2024 Mar; 30(3):730-739. PubMed ID: 38347302
[TBL] [Abstract] [Full Text] [Related]
8. Comparing the use of aggressive end-of life care among frail and non-frail patients with cancer using a claims-based frailty index.
Sachdev R; Shearn-Nance G; Vu L; Bensken WP; Douglas SL; Koroukian SM; Rose J
J Geriatr Oncol; 2024 Mar; 15(2):101706. PubMed ID: 38320468
[TBL] [Abstract] [Full Text] [Related]
9. Local Recurrence-Free Survival After TaTME: A Canadian Institutional Experience.
Hershorn O; Ghuman A; Karimuddin AA; Raval MJ; Phang PT; Brown CJ
Dis Colon Rectum; 2024 May; 67(5):664-673. PubMed ID: 38319633
[TBL] [Abstract] [Full Text] [Related]
10. Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer: a phase Ⅱ study.
Yang L; Zhang W; Fan N; Cao P; Cheng Y; Zhu L; Luo S; Zong H; Bai Y; Zhou J; Deng Y; Ba Y; Liu T; Aili M; Yin X; Gu K; Dai G; Ying J; Shi J; Gao Y; Li W; Yu G; Xie L; Gai W; Wang Y; Meng P; Shi Y
EBioMedicine; 2024 Feb; 100():104966. PubMed ID: 38217945
[TBL] [Abstract] [Full Text] [Related]
11. Unraveling the multifaceted role of EpCAM in colorectal cancer: an integrated review of its function and interplay with non-coding RNAs.
Jiang X; Wang S; Liang Q; Liu Y; Liu L
Med Oncol; 2023 Dec; 41(1):35. PubMed ID: 38151631
[TBL] [Abstract] [Full Text] [Related]
12. Does commission on cancer (CoC) accreditation mitigate the effect of care fragmentation on clinical outcome in localized rectal cancer?
Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
Am J Surg; 2024 Apr; 230():63-67. PubMed ID: 38148258
[TBL] [Abstract] [Full Text] [Related]
13. High Protein Oral Nutritional Supplements Enable the Majority of cancer Patients to Meet Protein Intake Recommendations during Systemic Anti-cancer treatment: A Randomised Controlled Parallel-Group Study.
Dingemans AM; van Walree N; Schramel F; Soud MY; Baltruškevičienė E; Lybaert W; Veldhorst M; van den Berg CA; Kaasa S
Nutrients; 2023 Dec; 15(24):. PubMed ID: 38140289
[TBL] [Abstract] [Full Text] [Related]
14. Outcomes of metachronous para-aortic lymphadenectomy in colorectal cancer: a systematic review of the literature.
Onafowokan OO; Redfern J; Patel A; Satyadas T; Baltatzis M
Langenbecks Arch Surg; 2023 Dec; 409(1):4. PubMed ID: 38091090
[TBL] [Abstract] [Full Text] [Related]
15. Lactobacillus paracasei R3 Alleviates Tumor Progression in Mice with colorectal cancer.
Chen T; Li B; Zheng K; Liu Y; Zhang Z; Hu H; Qian G; Jiang J
Curr Microbiol; 2023 Dec; 81(1):38. PubMed ID: 38091085
[TBL] [Abstract] [Full Text] [Related]
16. Efficacy and safety of immune checkpoint inhibitors for patients with prostate cancer: a systematic review and meta-analysis.
Noori M; Azizi S; Mahjoubfar A; Abbasi Varaki F; Fayyaz F; Mousavian AH; Bashash D; Kardoust Parizi M; Kasaeian A
Front Immunol; 2023; 14():1181051. PubMed ID: 38022569
[TBL] [Abstract] [Full Text] [Related]
17. Comparison of outcomes between surgical treatment of colorectal cancer metastatic to the liver and the peritoneum: Review of the literature.
Cos H; Shen P
J Surg Oncol; 2024 Jan; 129(1):85-90. PubMed ID: 37990864
[TBL] [Abstract] [Full Text] [Related]
18. Surgical cancer Care in Safety-Net Hospitals: a Systematic Review.
Wong P; Victorino GP; Sadjadi J; Knopf K; Maker AV; Thornblade LW
J Gastrointest Surg; 2023 Dec; 27(12):2920-2930. PubMed ID: 37968551
[TBL] [Abstract] [Full Text] [Related]
19. Prevalence of alexithymia in cancer patients: a systematic review and meta-analysis.
Liu Y; Du Q; Jiang Y
Support Care Cancer; 2023 Nov; 31(12):675. PubMed ID: 37932546
[TBL] [Abstract] [Full Text] [Related]
20. Negative hyperselection of elderly patients with RAS and BRAF wild-type metastatic colorectal cancer receiving initial panitumumab plus FOLFOX or 5-FU/LV.
Pietrantonio F; Bergamo F; Rossini D; Ghelardi F; De Grandis MC; Germani MM; Barsotti G; Formica V; Frassineti GL; Boscolo G; Cinieri S; Di Donato S; Antonuzzo L; Antoniotti C; Ambrosini M; Piva VM; Nichetti F; Fassan M; Cremolini C; Lonardi S
Eur J Cancer; 2023 Dec; 195():113396. PubMed ID: 37924647
[TBL] [Abstract] [Full Text] [Related]
[Next]
